{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:57:26Z","timestamp":1791122246556,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.autrev.2014.01.041","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T12:30:17Z","timestamp":1389443417000},"page":"441-444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["The diagnosis of primary biliary cirrhosis"],"prefix":"10.1016","volume":"13","author":[{"given":"Christopher L.","family":"Bowlus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.01.041_bb0005","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.gastro.2003.08.022","article-title":"Pediatric-onset primary biliary cirrhosis","volume":"125","author":"Dahlan","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0010","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of primary biliary cirrhosis in a US community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2004.04.064","article-title":"Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations","volume":"127","author":"Sood","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/hep.510270303","article-title":"Characterization of antimitochondrial antibodies in health adults","volume":"27","author":"Mattalia","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2005-916319","article-title":"Genetics and geoepidemiology of primary biliary cirrhosis: following the footprints to disease etiology","volume":"25","author":"Selmi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2014.01.041_bb0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/MEG.0b013e328277594a","article-title":"Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community","volume":"19","author":"Pla","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/bmj.281.6243.772","article-title":"Primary biliary cirrhosis: an epidemiological study","volume":"281","author":"Triger","year":"1980","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2014.01.041_bb0040","first-page":"42","article-title":"Epidemiology of PBC in Sheffield updated: demographics and relation to water supply","volume":"48","author":"Ray-Chadhuri","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2014.01.041_bb0045","first-page":"377","article-title":"The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?","volume":"75","author":"Myszor","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2014.01.041_bb0050","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/hep.510300213","article-title":"Primary biliary cirrhosis once rare, now common in the United Kingdom?","volume":"30","author":"James","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0055","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.autrev.2008.06.009","article-title":"Is autoimmunity a matter of sex?","volume":"7","author":"Lleo","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.01.041_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/gut.25.2.133","article-title":"Bacteriuria and primary biliary cirrhosis","volume":"25","author":"Burroughs","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2014.01.041_bb0065","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/gut.2009.184218","article-title":"Case\u2013control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2014.01.041_bb0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.21076","article-title":"Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites","volume":"43","author":"Ala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0080","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/hep.23139","article-title":"Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space\u2013time clustering analysis","volume":"50","author":"McNally","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"Primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"EASL","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0095","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis of primary biliary cirrhosis","volume":"39","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2014.01.041_bb0100","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0105","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1073\/pnas.85.22.8654","article-title":"Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis","volume":"85","author":"Fussey","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2014.01.041_bb0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/hep.1840100402","article-title":"Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis","volume":"10","author":"Mutimer","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0115","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1073\/pnas.90.6.2527","article-title":"Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis","volume":"90","author":"Cha","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2014.01.041_bb0120","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.autrev.2014.01.041_bb0130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0145","first-page":"1257","article-title":"Primary biliary cirrhosis","volume":"60","author":"Scheuer","year":"1967","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.autrev.2014.01.041_bb0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis\u2013autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0155","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","article-title":"Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes","volume":"102","author":"Silveira","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1541-0420.2007.00825.x","article-title":"Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends","volume":"64","author":"Telesca","year":"2008","journal-title":"Biometrics"},{"key":"10.1016\/j.autrev.2014.01.041_bb0165","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0175","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1053\/gast.2002.36027","article-title":"Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28years","volume":"123","author":"Prince","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1572-0241.1999.00770.x","article-title":"Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis","volume":"94","author":"Springer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0190","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2008.07.019","article-title":"Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment","volume":"135","author":"Huet","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0195","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0205","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Pares","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0168-8278(99)80222-0","article-title":"Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group","volume":"31","author":"van Hoogstraten","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0215","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0220","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0230","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s10620-010-1291-5","article-title":"Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid","volume":"55","author":"Kaplan","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2014.01.041_bb0235","first-page":"CD004385","article-title":"Methotrexate for primary biliary cirrhosis","author":"Giljaca","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2014.01.041_bb0240","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0245","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(10)60004-9","article-title":"Farnesoid-X receptor agonists: a new class of drugs for the treatment of PBC? An international study evaluating the addition of INT-747 (obeticholic acid) to ursodeoxycholic acid","volume":"52","author":"Mason","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0250","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ajg.2013.51","article-title":"B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid","volume":"108","author":"Myers","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0255","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.24748","article-title":"Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"55","author":"Tsuda","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0260","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-60761-720-4_14","article-title":"Animal models of primary biliary cirrhosis: materials and methods","volume":"900","author":"Leung","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.autrev.2014.01.041_bb0265","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep.26067","article-title":"Therapeutic effect of cytotoxic T lymphocyte antigen 4\/immunoglobulin on a murine model of primary biliary cirrhosis","volume":"57","author":"Dhirapong","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2013.07.001","article-title":"Role of theintestinal microbiome in liver disease","volume":"46","author":"Henao-Mejia","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.08.006","article-title":"Liver auto-immunology: the paradox of autoimmunity in a tolerogenic organ","volume":"46","author":"Invernizzi","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseasesprovided by genome-wide association studies","volume":"46","author":"Mells","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaut.2013.06.015","article-title":"The limitations and hiddengems of the epidemiology of primary biliary cirrhosis","volume":"46","author":"Podda","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0295","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jaut.2013.06.014","article-title":"Clinical management of autoimmune biliarydiseases","volume":"46","author":"Imam","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0300","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaut.2012.12.007","article-title":"Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA","volume":"41","author":"Leung","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0305","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","article-title":"Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis","volume":"41","author":"Wang","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.01.041_bb0310","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.26418","article-title":"Clonality, activated antigen-specific CD8+ T cells, and development of autoimmune cholangitis in dnTGF\u03b2RII mice","volume":"58","author":"Kawata","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0315","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.25829","article-title":"Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGF\u03b2 receptor type II mice","volume":"57","author":"Tsuda","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0320","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/hep.25803","article-title":"The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice","volume":"56","author":"Ando","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2014.01.041_bb0325","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.26157","article-title":"Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis","volume":"57","author":"Chen","year":"2013","journal-title":"Hepatology"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T19:17:42Z","timestamp":1688930262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":65,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1568997214000536"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.041","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnosis of primary biliary cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}